Company news
Telix Pharmaceuticals Limited (ASX:TLX) news
Telix Pharmaceuticals Limited news releases on 6ix. Latest, Aug 8, 2019: Telix and GenesisCare Commence Prostate Cancer Study
Press releases — page 7
Telix and GenesisCare Commence Prostate Cancer Study
August 7, 2019
Telix and Merck Group Combination Therapy Collaboration
July 31, 2019
Sales Note to Accompany June 2019 Quarter Appendix 4C
July 30, 2019
Telix Receives $9.3m R&D Tax Refund
July 18, 2019
Investor Presentation
July 16, 2019
Telix Reports Positive Phase III Meeting with the FDA
July 14, 2019
Telix and Monrol Manufacturing and Distribution Agreement
June 13, 2019
Telix and Osaka University Extend Collaboration
June 11, 2019
Prostate Imaging Program - Commercial and Regulatory Update
May 28, 2019
Appendix 4C - March 2019 Quarter
April 29, 2019
Fractionated Prostate Cancer Therapy Published
April 25, 2019
Non-Deal Roadshow Presentation March-April 2019
March 26, 2019
Appendix 4C - December 2018 quarter
January 30, 2019
Telix Group Expands Prostate Imaging Capability through ININ
January 23, 2019
Detailed Program Update - January 2019
January 8, 2019
Update - Acceleration of Prostate Cancer Therapy Program
January 7, 2019
Telix Pharmaceuticals Completes Acquisition of ANMI SA
December 23, 2018
Nihon Medi-Physics Collaboration on Actinium Renal Cancer
November 28, 2018
ANMI Transaction - Market Briefing
November 25, 2018
Appendix 4C - September Quarter
October 30, 2018
Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial
October 22, 2018
Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
October 14, 2018
Strategic Collaboration Agreement with GenesisCare
October 9, 2018
Telix completes acquisition of Atlab Pharma
September 10, 2018
TLX receives ethics approval to commence Glioblastoma Study
September 3, 2018
Half Yearly Report and Accounts
August 30, 2018
Telix files Ph III trial for Kidney Cancer Imaging in Europe
August 22, 2018
Collaboration on Renal Cancer Imaging for Japanese market
August 15, 2018
Telix JV Entity Extends Contract with Endocyte to Include EU
August 9, 2018
Telix receives $55m Overseas Finding
August 2, 2018
Appendix 4C - June 2018 Quarter
July 26, 2018
TLX and JFE progress Japanese manufacturing partnership
July 25, 2018
Prostate imaging regulatory update - FDA review of DMF
July 24, 2018
Telix and Isologic conclude manufacturing agreement
June 25, 2018
SEIF Grant Awarded for Advanced Biologics Manufacturing
June 17, 2018
Telix and Osaka U receive funding for Alpha Nuclide Research
May 29, 2018
Appendix 4C - March 2018 quarter
April 26, 2018
Translational Research Partnership with INSERM and ARRONAX
April 15, 2018
Telix JV Entity Contract with Endocyte for Prostate Imaging
April 9, 2018
Update - prostate imaging program
March 28, 2018
Drug Master File for Prostate Imaging Product Filed with FDA
March 25, 2018
Telix and Radboud University Medical Centre Collaboration
March 14, 2018
Appendix 4E and 2017 Annual Report
February 25, 2018
Shareholder Update
February 21, 2018
Appendix 4C - December 2017 quarter
January 29, 2018
Telix establishes Japanese subsidiary
January 15, 2018
Renal Cancer Collaboration with Memorial Sloan Kettering
December 13, 2017
Manufacturing Partnership with JFE Engineering Corporation
December 12, 2017
Admission to Official List
November 15, 2017